|
Doxycycline |
Details
|
Doxycycline is a bacteria fighting tetracycline antibiotic used in treating various types of bacterial infections, like gonorrhea, urinary tract infections, acne, periodontitis, and Chlamydia. If you plan on using Doxycycline and are currently having kidney disease complications you should notify your doctor first. This drug must be taken with a full glass of water, with milk, food, or on an empty stomach. Avoid the use of antacids, multivitamins, iron supplements, and laxatives 2 hours prior to using Doxycycline because these medications can interact with the effectiveness of Doxycycline. This medication should be taken on a regular basis for full benefits. Common related side effects that can result from this drug include: swollen tongue, vaginal or yeast infection, sun sensitivity, diarrhea, vomiting, and nausea. If you experience a serious allergic attack, severe headaches, confusion, changes in vision, or liver damage while taking Doxycycline you should stop this medication right away and seek emergency help. Doxycycline could potentially decrease birth control effectiveness; therefore a second form of birth control should be used to ensure protection. If you suspect symptoms of overdose such as vomiting, diarrhea, and nausea, you should seek medical attention right away. Keep Doxycycline stored at room temperature, far away from reach of children. To obtain full prescribing information, consult with your pharmacist or primary physician. Some additional useful details about Doxycycline.Com highlight the following: Doxicycline has been also used in treating individuals exposed to anthrax and has been used since the 1950’s in the United States. This drug was recommended to be used during anthrax scares in 2001 by the Centers for Disease Control and Prevention. You should always discuss with your doctor any concerns you may have before starting Doxycycline.
|
| Category |
Drugs and Medicine > D
|
| Related Searches |
Doxicycline, buy doxycycline hyclate, urinary problems in men |
| Date Submitted |
27-Oct-2005
|
|
